Liberty Expedia Holdings (LEXEB:NAS) and PDL BioPharma (PDLI:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
LEXEB Liberty Expedia Holdings Inc 45.137500 57327005 None 1.1246 65.68 -7.99
LEXEA Liberty Expedia Holdings Inc 42.470000 57327005 None 1.0581 65.68 -7.99
SOHU Sohu.com Ltd 18.660000 39228538 None 1.3675 21.38 12.30
PDLI PDL BioPharma Inc 3.260000 120654947 None 0.5390 3.27 2.24
ZVO Zovio Inc 5.000000 29927779 34.6471 1.2267 5.56 5.27
APTX Aptinyx Inc 3.800000 33562211 None 0.8542 4.49 None
MGI MoneyGram International Inc 2.160000 56386051 None None 2.58 -13.40
ASLN ASLAN Pharmaceuticals Ltd 3.700000 32049788 None 3.8730 27.57 14.24
SORL SORL Auto Parts Inc 3.610000 19304921 5.4697 0.3945 3.81 -9.32
AQXP Aquinox Pharmaceuticals Inc 2.770000 23537368 None 0.9113 3.15 3.15
SCPH scPharmaceuticals Inc 3.500000 18580430 2.6622 0.8754 4.82 4.30
CDTX Cidara Therapeutics Inc 2.110000 26641851 None 0.9505 2.80 2.43
MLNT Melinta Therapeutics Inc 3.450000 11779897 None 0.2138 6.94 -2.43
TST TheStreet Inc 6.620000 5336639 3.2090 0.6358 6.94 8.63
PDSB PDS Biotechnology Corp 6.330000 5348174 None 1.1345 6.48 10.11
APWC Asia Pacific Wire & Cable Corp Ltd 2.250000 13819669 10.7143 0.2073 4.40 2.60
ADXS Advaxis Inc 3.380000 8006984 None 0.7217 4.09 14.08
GIGM GigaMedia Ltd 2.400000 11052235 28.0000 0.4602 5.25 5.77
TRMT Tremont Mortgage Trust 7.980000 3178817 None 0.4251 8.50 -1.40
GEVO Gevo Inc 2.080000 11885678 None 0.2784 2.84 1.78
TNXP Tonix Pharmaceuticals Holding Corp 2.000000 6089728 None 0.5147 4.11 7.16
KBSF KBS Fashion Group Ltd 3.870000 2591299 None 0.1847 8.11 7.69
ADYX Adynxx Inc 7.071200 834203 None 0.7986 9.27 -13.54
SHIP Seanergy Maritime Holdings Corp 1.820000 2809223 None 0.2400 2.38 -71.29
BLIN Bridgeline Digital Inc 5.970000 324825 None 0.4951 6.47 -1.29

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

LEXEB:NAS Liberty Expedia Holdings

http://www.libertyexpedia.com
Liberty Expedia Holdings has 24500 employees and is headquartered in United States.
Liberty Expedia Holdings Inc is an online travel company. It operates a strong brand portfolio with global reach, targeting a broad range of travelers, travel suppliers, and advertisers.

PDLI:NAS PDL BioPharma

http://www.pdl.com
PDL BioPharma has 105 employees and is headquartered in United States.
PDL BioPharma Inc is engaged in the discovery of a new generation of targeted treatments for cancer and immunologic diseases. It focuses on intellectual property asset management, investing in new royalty bearing assets and maximizing value of its patent.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.